Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Activin A secretion by muscle-repairing macrophages induces heterotopic ossification in mice
Wenqiang Yin, Kazuo Okamoto, Asuka Terashima, Warunee Pluemsakunthai, Takehito Ono, Taku Ito-Kureha, Shizuo Akira, Yoshinobu Hashizume, Roland Baron, Satoshi Ueha, Kouji Matsushima, Martin M. Matzuk, Yuji Mishina, Hiroshi Takayanagi
Wenqiang Yin, Kazuo Okamoto, Asuka Terashima, Warunee Pluemsakunthai, Takehito Ono, Taku Ito-Kureha, Shizuo Akira, Yoshinobu Hashizume, Roland Baron, Satoshi Ueha, Kouji Matsushima, Martin M. Matzuk, Yuji Mishina, Hiroshi Takayanagi
View: Text | PDF
Research Article Bone biology Immunology Muscle biology

Activin A secretion by muscle-repairing macrophages induces heterotopic ossification in mice

  • Text
  • PDF
Abstract

The immune system is not only essential for host defense, but it is also involved in tissue maintenance and disease pathogenesis. Macrophages play a key role in tissue repair, fibrosis, and tumorigenesis, but the mechanisms underlying their multifunctionality have not been fully explored. Here, we identified Mrep (Ly6ChiCX3CR1loPDPN+CD9+) as a crucial subset of macrophages for muscle regeneration after muscle injury. Muscle regeneration required Mrep-derived activin A, which was produced via the TLR4/TIR domain–containing adapter-inducing interferon-β/TANK-binding kinase 1/interferon regulatory factor 3/7 signaling pathway in response to muscle injury. Mrep exerted pathological effects by secreting activin A in a model of genetically induced heterotopic ossification (HO), which was suppressed by TLR4 inhibition. Thus, this study elucidates the context-dependent functions of macrophages and the link between injury and HO, suggesting that Mrep is a potential therapeutic target for regenerating muscles and suppressing HO.

Authors

Wenqiang Yin, Kazuo Okamoto, Asuka Terashima, Warunee Pluemsakunthai, Takehito Ono, Taku Ito-Kureha, Shizuo Akira, Yoshinobu Hashizume, Roland Baron, Satoshi Ueha, Kouji Matsushima, Martin M. Matzuk, Yuji Mishina, Hiroshi Takayanagi

×

Figure 7

Activin A expression in Mrep is induced via the TRIF/TBK1/IRF3/7 signaling pathway.

Options: View larger image (or click on image) Download as PowerPoint
Activin A expression in Mrep is induced via the TRIF/TBK1/IRF3/7 signali...
(A and B) RT-qPCR results showing the relative Inhba expression in muscles of indicated mice at 1 dpi (A) and 4 dpi (B). Uninjured (n = 9); 1 dpi: WT (n = 6), Myd88–/– (n = 4), Ticam1–/– (n = 5); 4 dpi: WT (n = 3), Myd88–/– (n = 5), Ticam1–/– (n = 9). (C) RT-qPCR results showing relative Inhba expression in the Mrep cells sorted from WT (n = 9) and Ticam1–/– (n = 6) mice at 1 dpi. (D) RT-qPCR showing relative Inhba mRNA expression in muscles at 1 dpi in WT mice treated with vehicle (n = 7), TBK1 inhibitor (n = 5), or NF-κB inhibitor (n = 4). (E) RT-qPCR results showing relative Inhba mRNA expression in BMDMs derived from WT (n = 5), Irf3–/– (n = 4), or Irf7–/– mice (n = 4) stimulated with LPS for 1 day. (F) ChIP-seq (GEO GSE38377) showing RNA polymerase II (Pol II) and H3K4me3 occupancy in untreated and LPS-stimulated BMDMs at 24 hours. The Inhba gene is shown as a blue line with 3 exons indicated by blue boxes. Upon LPS treatment, a prominent RNA Pol II peak appeared approximately 2 kb upstream of the transcription start site (TSS), indicating the promoter. H3K4me3 enrichment in the same region indicates active chromatin. The promoter contains an interferon-stimulated responsive element (ISRE) motif recognized by IRF3 and IRF7, with its sequence and location shown in the inset. The P values were calculated using unpaired 2-tailed t test (C) and 1-way ANOVA with Tukey’s multiple-comparison test (A, B, D, and E). A P value < 0.05 was considered significant. Data are shown as the mean ± SEM, and symbols represent individual mice (A–E).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts